Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid β-peptide

SD Yan, SF Yan, X Chen, J Fu, M Chen… - Nature medicine, 1995 - nature.com
SD Yan, SF Yan, X Chen, J Fu, M Chen, P Kuppusamy, MA Smith, G Perry, GC Godman…
Nature medicine, 1995nature.com
Paired helical filament (PHF) tau is the principal component of neurofibriliary tangles, a
characteristic feature of the neurodegenerative pathology in Alzheimer's disease (AD). Post-
translational modification of tau, especially phosphorylation, has been considered a major
factor in aggregation and diminished microtubule interactions of PHF-tau. Recently, it has
been recognized that PHF-tau is also subject to non-enzymatic glycation, with formation of
advanced glycation end products (AGEs). We now show that as a consequence of glycation …
Abstract
Paired helical filament (PHF) tau is the principal component of neurofibriliary tangles, a characteristic feature of the neurodegenerative pathology in Alzheimer's disease (AD). Post-translational modification of tau, especially phosphorylation, has been considered a major factor in aggregation and diminished microtubule interactions of PHF-tau. Recently, it has been recognized that PHF-tau is also subject to non-enzymatic glycation, with formation of advanced glycation end products (AGEs). We now show that as a consequence of glycation, PHF-tau from AD and AGE-tau generate oxygen free radicals, thereby activating transcription via nuclear factor-κB, increasing amyloid β-protein precursor and release of ∼4 kD amyloid β-peptides. These data provide insight into how PHF-tau disturbs neuronal function, and add to a growing body of evidence that oxidant stress contributes to the pathogenesis of AD.
nature.com